<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-gb" lang="en-gb" >

<head>
	  <base href="http://www.pers-project.com/" />
  <meta http-equiv="content-type" content="text/html; charset=utf-8" />
  <meta name="robots" content="index, follow" />
  <meta name="keywords" content="PERS - Paediatric European Risperidone Studies" />
  
  <meta name="author" content="Administrator" />
  <meta name="description" content="PERS - Paediatric European Risperidone Studies" />
  
  <title>PERS aims to increase the safety of off-label antipsychotics prescription to minors</title>
  <link href="/templates/pers/favicon.ico" rel="shortcut icon" type="image/x-icon" />
  <script type="text/javascript" src="/media/system/js/mootools.js"></script>
  <script type="text/javascript" src="/media/system/js/caption.js"></script>

	<link rel="stylesheet" href="/templates/system/css/system.css" type="text/css" />
	<link rel="stylesheet" href="/templates/system/css/general.css" type="text/css" />
	<link rel="stylesheet" href="/templates/pers/css/template.css" type="text/css" />
	<link rel="stylesheet" href="/templates/pers/css/editor.css" type="text/css" />
	<link rel="stylesheet" href="/templates/pers/css/system.css" type="text/css" />
	<script type="text/javascript" src="/templates/pers/js/utils.js"></script>
<!--[if IE]>
	<link rel="stylesheet" href="/templates/pers/css/ieonly.css" type="text/css" />
<![endif]-->
<!--[if lte IE 6]>
	<link rel="stylesheet" href="/templates/pers/css/ie6only.css" type="text/css" />
	<script type="text/javascript" src="/templates/pers/js/supersleight-min.js"></script>
<![endif]-->
		<style type="text/css">
		#st_header_out {
			background: #FFF url("/templates/pers/images/header_bgr_0.jpg") 10px 0 no-repeat;
		}
	</style>
</head>

<body>
	<div id="st_header_out" class="clearfix">
		<div id="st_logo"><a href="/"><img src="/templates/pers/images/logo.png" alt="" /></a></div>
			</div>
	<div id="st_mainmenu_out" class="clearfix">
		<div id="st_mainmenu">
							<table width="100%" border="0" cellpadding="0" cellspacing="0"><tr><td nowrap="nowrap"><span id="st_menu_1" class="active firstactive"><a href="/" class="mainlevel" id="active_menu">Home</a></span><span id="st_menu_5" class="neighbour"><a href="/index.php/project-summary/" class="mainlevel" >About PERS</a></span><span id="st_menu_6" class=""><a href="/index.php/what-is-conduct-disorder/" class="mainlevel" >Conduct Disorder</a></span><span id="st_menu_7" class=""><a href="/index.php/aims-of-the-pers-study/" class="mainlevel" >The PERS study</a></span><span id="st_menu_8" class=""><a href="/index.php/why-should-i-or-my-kid-participate-in-the-pers-studies/" class="mainlevel" >Patients and relatives</a></span><span id="st_menu_9" class=""><a href="/index.php/websites-for-professionals/" class="mainlevel" >Resources</a></span></td></tr></table>
					</div>
		<div id="st_topmenu">
							<table width="100%" border="0" cellpadding="0" cellspacing="0"><tr><td nowrap="nowrap"><span id="st_menu_4" class="first"><a href="/index.php/Log-in/" class="mainlevel" >Members</a></span></td></tr></table>
								</div>
	</div>
	<div id="st_breadcrumbs_out" class="clearfix">
		<div id="st_breadcrumbs">
							<label>You are here: </label>Home				<span class="breadcrumbs pathway">
</span>

					</div>
	</div>
	<div id="st_middle_out">
		<div id="st_middle" class="clearfix">
									<div id="st_content_mid">
				
				<table class="contentpaneopen" cellpadding="0" cellspacing="0">
<tr>
		<td class="contentheading" width="100%">
		<h1 class="title">
				<a href="/" class="contentpagetitle">
			PERS aims to increase the safety of off-label antipsychotics prescription to minors</a>
				</h1>
	</td>
	</tr>
</table>

<table class="contentpaneopen" cellpadding="0" cellspacing="0">



<tr>
<td valign="top">
<p><img src="/images/stories/intro/intro_library.jpg" border="0" alt="library" /></p>
<p class="intro">The Pediatric European Risperidone Studies (PERS) address the topic of the FP7-Health-4.2-1 work program “Adapting off-patent medicines to the specific needs of paediatric populations”. Risperidone, a second-generation antipsychotic, is widely prescribed to children and adolescents in a variety of conditions such as psychotic disorders, externalizing symptoms associated with autism or mental retardation, aggressive behavior in disruptive behavior disorders.</p>
<p>The PERS project addresses major gaps in the evidence-base of the use of risperidone for the treatment of conduct disorder in children and adolescents. PERS proposes 3 clinical studies that will provide information on efficacy and tolerability for the use of risperidone in children and adolescents with conduct disorder and long term safety of risperidone in children and adolescents receiving risperidone for a variety of conditions.</p>
<table style="width: 100%;" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td align="left" valign="top">
<div class="teaser">
<div class="teaser_top">
<div class="teaser_bottom"><img class="teaser_img" src="/images/stories/intro/intro_disorder.png" border="0" alt="disorder" style="float: left; border: 0pt none;" />
<p class="teaser_title">What is conduct<br />disorder?</p>
<p class="teaser_readon"><a href="/index.php/what-is-conduct-disorder/">Some basic facts and figures</a></p>
</div>
</div>
</div>
</td>
<td align="left" valign="top">
<div class="teaser_right">
<div class="teaser_top">
<div class="teaser_bottom"><img class="teaser_img" src="/images/stories/intro/intro_pers.png" border="0" alt="pers" style="float: left; border: 0pt none;" />
<p class="teaser_title">What is<br />PERS?</p>
<p class="teaser_readon"><a href="/index.php/project-summary/">Some basic facts and figures</a></p>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table></td>
</tr>

</table>
<a href="#" title="Top" class="toplink">Top</a><br class="clear" />
<div id="mfoofill"></div>
<div id="st_icons">
		<td align="right" width="100%" class="buttonheading">
	<a href="/index.php/pers-seeking-new-treatments-for-conduct-disorder-in-children-and-adolescents/Print/" title="Print page" onclick="window.open(this.href,'win2','status=no,toolbar=no,scrollbars=yes,titlebar=no,menubar=no,resizable=yes,width=640,height=480,directories=no,location=no'); return false;" rel="nofollow" class="icon_print">Print page</a>	</td>
	
		<td align="right" width="100%" class="buttonheading">
	<a href="/index.php/?format=phocapdf" title="PDF" onclick="window.open(this.href,'win2','status=no,toolbar=no,scrollbars=yes,titlebar=no,menubar=no,resizable=yes,width=640,height=480,directories=no,location=no'); return false;" rel="nofollow" class="icon_pdf">Save page as PDF&nbsp;</a>	</td>
	
		</div>
<span class="article_separator">&nbsp;</span>

			</div>
										<div id="st_rightcol_wide">
					<div id="st_colsep" class="clearfix">
								<div class="moduletable_yellow">
					<h3>News</h3>
					<p class="blacktext"><strong><span class="bluetext">July 11, 2013</span></strong><span class="st"><span class="blacktext"><br /></span>The British regulatory agency MHRA put a recall on </span>our medicine for CONCA and DISCONCA (WP2, WP3)! Both short-term studies are on hold (no patients enrolled)!</p>
<p class="bluetext"><strong class="bluetext">November 2013</strong><span class="bluetext"><br /><span class="blacktext">First</span></span><span class="bluetext"><span class="blacktext"> PERS publication accepted in <span style="mso-bidi-font-weight: normal;">European Child and Adolescent Psychiatry</span>: Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges. </span> </span></p>
<p class="bluetext"><strong class="bluetext">March 2014</strong><span class="bluetext"><br /><span class="blacktext">Potential study sponsor (Janssen-Cilag) dropped off; no reproduction of the tablets for WP2 and WP3 possible. </span></span><span style="color: #000000;">Consortium strongly supports successfully ongoing observational naturalistic study. Recruitment is ongoing across a series of sites in Spain, Italy and France.</span></p>
<div><span class="bluetext"><span class="blacktext"><strong><span class="st"><span class="bluetext">Summer 2014</span></span></strong></span></span></div>
<div>German sites received ethics approvals and can start the observational study at both sites.</div>
<div></div>
<div><strong><span class="st"><span class="bluetext">November 2014</span></span></strong></div>
<div>The consortium cordially welcomes KCL, London, as new PERS WP4 recruitment site!</div>
<div>
<div></div>
<div><strong><span class="st"><span class="bluetext">December 2014</span></span></strong></div>
<div>Nearly 300 pediatric patients take part in our prospective observational trial. Recruitment is ongoing in The Netherlands, Germany, UK, Spain, France, and Italy!</div>
<div>
<div></div>
</div>
</div>		</div>
			<div class="moduletable_blue">
					<h3>Events</h3>
					<div class="ne_container_last">
<p class="bluetext"><strong>Conference calls</strong></p>
<p><span style="text-decoration: underline;"><strong class="blacktext">Past (2014)</strong></span></p>
<ul>
<li>January 6, 2014</li>
<li>February 10, 2014</li>
<li>March 10, 2014</li>
<li>April 8, 2014</li>
<li>May 5, 2014</li>
<li>June 2, 2104</li>
<li>July 7, 2014</li>
<li>(no TC in August)</li>
<li>September 1, 2014</li>
<li>October 6, 2014</li>
<li>November 3, 2014</li>
<li>December 1, 2014</li>
<li>January 12, 2015 (2nd Monday!)</li>
<li>February 2, 2015</li>
</ul>
<p><span style="text-decoration: underline;"><strong>Upcoming</strong></span></p>
<ul>
<li>March x 2015: <strong class="bluetext">RESCHEDULED</strong>!</li>
</ul>
<strong>New TC date not set; please check for update!</strong> 
<ul>
</ul>
</div>		</div>
	
						<div id="rfoofill"></div>
					</div>
				</div>
					</div>
	</div>
	<div id="st_footer_out">
		<div id="st_footer" class="clearfix">
									<div id="st_bottommenu" class="clearfix">
								<div class="moduletable">
					<ul class="menu"><li class="parent item11"><a href="/index.php/project-summary/"><span>About PERS</span></a><ul><li class="item70"><a href="/index.php/project-summary/"><span>Project Summary</span></a></li><li class="item12"><a href="/index.php/coordinator-and-project-office/"><span>Coordinator and Project Office</span></a></li><li class="item72"><a href="/index.php/members/"><span>Members</span></a></li><li class="item16"><a href="/index.php/scientific-advisory-board/"><span>Scientific Advisory Board</span></a></li><li class="item17"><a href="/index.php/organisation/"><span>Organisation</span></a></li></ul></li><li class="parent item15"><a href="/index.php/what-is-conduct-disorder/"><span>Conduct disorder</span></a><ul><li class="item84"><a href="/index.php/what-is-conduct-disorder/"><span>What is it?</span></a></li><li class="item91"><a href="/index.php/how-frequent-is-conduct-disorder/"><span>Frequency</span></a></li><li class="item92"><a href="/index.php/what-do-we-know-about-risk-factors-cause-of-conduct-disorder/"><span>Risk factors</span></a></li><li class="item93"><a href="/index.php/what-is-the-outcome-of-conduct-disorder/"><span>Outcome</span></a></li><li class="item94"><a href="/index.php/what-drug-treatments-help-conduct-disorder/"><span>Drug treatments</span></a></li><li class="item95"><a href="/index.php/what-non-drug-treatments-help-conduct-disorder/"><span>Non-drug treatments</span></a></li></ul></li><li class="parent item22"><a href="/index.php/aims-of-the-pers-study/"><span>The PERS study</span></a><ul><li class="item13"><a href="/index.php/aims-of-the-pers-study/"><span>Aims of the PERS study</span></a></li><li class="item14"><a href="/index.php/work-packages/"><span>Work packages</span></a></li></ul></li><li class="parent item20"><a href="/index.php/why-should-i-or-my-kid-participate-in-the-pers-studies/"><span>Patients and relatives</span></a><ul><li class="item60"><a href="/index.php/pers-for-laymen/"><span>PERS “for laymen”</span></a></li><li class="item97"><a href="/index.php/what-should-i-or-my-kid-know-about-disruptive-disorders/"><span>What to know?</span></a></li><li class="item18"><a href="/index.php/why-should-i-or-my-kid-participate-in-the-pers-studies/"><span>Why participate?</span></a></li><li class="item107"><a href="/index.php/how-can-i-or-my-kid-participate-in-the-pers-studies/"><span>How to participate?</span></a></li></ul></li><li class="parent item27"><a href="/index.php/websites-for-professionals/"><span>Resources</span></a><ul><li class="item102"><a href="/index.php/websites-for-professionals/"><span>Links</span></a></li><li class="item103"><a href="/index.php/recommended-readings/"><span>Recommended Readings</span></a></li><li class="item105"><a href="/index.php/publications/"><span>Publications</span></a></li><li class="item134"><a href="/index.php/more-information/"><span>More Information</span></a></li></ul></li><li class="item10"><a href="/index.php?option=com_qcontacts&amp;view=contact&amp;id=64&amp;Itemid=10"><span>Contact</span></a></li><li class="item3"><a href="/index.php/terms-and-conditions/"><span>Legal disclaimer</span></a></li></ul>		</div>
	
					</div>
													<div id="st_copy">
									<div class="moduletable">
					<p>© 2011 PERS: Paediatric European Risperidone Studies</p>		</div>
	
					</div>
													<div id="st_europe">
									<div class="moduletable">
					<table style="width: 100%;" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td style="width: 50px;" align="left" valign="middle"><img src="/images/stories/eu_flag.gif" border="0" alt="EU flag" width="39" height="26" /></td>
<td align="left" valign="middle">The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) <br />under grant agreement n° 241959.</td>
</tr>
</tbody>
</table>		</div>
	
					</div>
						</div>
			</div>
</body>
<script language="javascript">
	var actheader = document.getElementById('st_menu_'+0);
	if (actheader) {
		actheader.className = 'active';
		actlink = actheader.getElementsByTagName('a')[0];
		if (actlink) {
			actlink.id = 'active_menu';
		}
	}
	var nheader = document.getElementById('st_menu_'+0);
	if (nheader) {
		nheader.className = 'neighbour';
	}
	function setFooFill() {
		var lcol = document.getElementById('st_leftcol');
		var rcol = document.getElementById('st_rightcol_wide');
		var mcol = document.getElementById('st_content_mid');
		var mfoo = document.getElementById('mfoofill');
		var lfoo = document.getElementById('lfoofill');
		var rfoo = document.getElementById('rfoofill');
		if (mfoo) mfoo.style.height = '0px';
		if (lfoo) lfoo.style.height = '0px';
		if (rfoo) rfoo.style.height = '0px';
		var lheight, rheight, mheight;
		lheight = lcol ? lcol.offsetHeight : 0;
		rheight = rcol ? rcol.offsetHeight : 0;
		mheight = mcol ? mcol.offsetHeight : 0;
		var maxheight = Math.max(lheight, rheight, mheight);
		if (mfoo && (mheight < maxheight)) {
			mfoo.style.height = (maxheight - mheight + 32) + 'px';
		}
		if (lfoo && (lheight < maxheight)) {
			if (maxheight - lheight - 32 > 0)
				lfoo.style.height = (maxheight - lheight - 32) + 'px';
			else
				mfoo.style.height = (maxheight - mheight + 32) + 'px';
		}
		if (rfoo && (rheight < maxheight)) {
			if (maxheight - rheight - 32 > 0)
				rfoo.style.height = (maxheight - rheight - 32) + 'px';
			else
				mfoo.style.height = (maxheight - mheight + 32) + 'px';
		}
		if (rfoo && (maxheight==lheight) && (rheight<maxheight)) {
			rfoo.style.height = (maxheight - rheight) + 'px';
		}
		if (lfoo && (maxheight==rheight) && (lheight<maxheight)) {
			lfoo.style.height = (maxheight - lheight) + 'px';
		}
	}
	function delayFooFill() {
		setTimeout('setFooFill()', 1);
	}
	window.onload = delayFooFill;
	function setCols (h, add) {
		var xmfoo = document.getElementById('mfoofill');
		var xlfoo = document.getElementById('lfoofill');
		var xlheight, xmheight;
		xlheight = xlfoo ? xlfoo.offsetHeight : 0;
		xmheight = xmfoo ? xmfoo.offsetHeight : 0;
		if (add) {
			xlfoo.style.height = (xlheight + h) + 'px';
			xmfoo.style.height = (xmheight + h) + 'px';
		}
		else {
			xlfoo.style.height = (xlheight - h) + 'px';
			xmfoo.style.height = (xmheight - h) + 'px';
		}
	}
</script>
<!--[if lte IE 6]>
<script language="javascript">
		supersleight.init();supersleight.limitTo('st_logo');supersleight.run();
</script>
<![endif]-->

</html>